We therefore applied Spa-RQ to investigate whether the classification of tumours based on MAPK/mTOR (OL; pERK/p4EBP1) or AKT/mTOR (OL; pAKT/p4EBP1) co-activation signatures translates to human samples. This evidence concerns the gene EIF2AK3 and neoplasm.